EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 3.0

Global perspective on gaps in fungal diagnostics in low-resource settings: WHO landscape analysis and research priorities for invasive fungal diseases

Maurine Murtagh, P Lewis White, Juan Luis Rodriguez-Tudela, Ana Alastruey-Izquierdo, Sharon C-A Chen, Philippe J Dufresne, Beatriz L Gómez, Guillermo Garcia-Effron, Betsy Wonderly Trainor, Pilar Garcia-Vello, Till T Bachmann, Pascale Ondoa und 4 weitere

The Lancet Microbe · 2026-05 · 7 (5) · 101307

DOI: 10.1016/j.lanmic.2025.101307 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The Lancet Microbe, 2026-05. Verfasst von Maurine Murtagh und 15 weiteren Autor:innen. Beteiligte Einrichtung: The Murtagh Group, Woodside, CA, USA; Antimicrobial Resistance (AMR) Department, WHO, Geneva, Switzerland. Hauptthemen laut MEDLINE: Fungi, Invasive Fungal Infections. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: World Health Organization, European Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Invasive fungal diseases (IFDs) are a growing global health threat, particularly in low-income and middle-income countries (LMICs), where diagnostic capacity is limited. The emergence and spread of antifungal resistance further complicate clinical management. Despite the high burden of IFDs, diagnostic development for fungal pathogens has lagged compared with that for its bacterial and viral counterparts. In this Review, we synthesised findings from WHO's 2024 diagnostic landscape analysis of fungal priority pathogens. We discussed the availability, accessibility, and performance of the current diagnostic tools, including phenotypic, immunological, and molecular methods, and identified key gaps in LMICs. WHO's research and development priorities for diagnostics for LMICs are also presented herein. The assessment reveals that most diagnostic platforms for IFDs are culture dependent, infrastructure intensive, and inaccessible at primary and secondary health-care levels in LMICs. Non-culture-based methods, such as lateral flow immunoassays and molecular diagnostics, are promising, but remain restricted in scope, species coverage, and affordability. Multiplex platforms capable of simultaneous broad pathogen detection and antifungal resistance testing are scarce. WHO has identified priority areas for diagnostic innovation, including simplified lateral flow immunoassays, automated culture systems, and integrated molecular platforms suitable for use in LMICs. Addressing diagnostic gaps for IFDs requires targeted investment in simplified, rapid, and affordable diagnostic tools that can be deployed across multiple levels of health-care system. WHO's research and development priorities aim to guide diagnostic developers and public health stakeholders in accelerating innovation and improving access to fungal diagnostics, particularly in LMICs, to reduce IFD-related morbidity and mortality.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FungiInvasive Fungal InfectionsHumansResource-Limited SettingsDeveloping CountriesGlobal HealthResearchDrug Resistance, FungalRapid Diagnostic Tests

Autor:innen und Institutionen

  • The Murtagh Group, Woodside, CA, USA; Antimicrobial Resistance (AMR) Department, WHO, Geneva, Switzerland.
  • Public Health Wales Microbiology, Cardiff, UK.
  • Global Action for Fungal Infections, Geneva, Switzerland.
  • Mycology Reference Laboratory, National Centre for Microbiology, Instituto de Salud Carlos III, Madrid, Spain.
  • Clinical Mycology Reference Laboratory, Centre for Infectious Diseases and Microbiology Laboratory Services, Institute of Clinical Pathology and Medical Research, Westmead Hospital, Westmead, NSW, Australia.
  • Mycology Reference Laboratory, Laboratoire de Santé Publique du Québec, Institut National de Santé Publique du Québec, Sainte-Anne-de-Bellevue, QC, Canada.

Förderung

  • World Health Organization
  • European Commission

Zitieren

APA

Murtagh, M., White, P. L., Rodriguez-Tudela, J. L., Alastruey-Izquierdo, A., Chen, S. C., Dufresne, P. J., Gómez, B. L., Garcia-Effron, G., Trainor, B. W., Garcia-Vello, P., Bachmann, T. T., Ondoa, P., Marcano Zamora, D., Rocke, T., Cameron, A., & Gigante, V. (2026). Global perspective on gaps in fungal diagnostics in low-resource settings: WHO landscape analysis and research priorities for invasive fungal diseases. The Lancet Microbe, 7(5), 101307. https://doi.org/10.1016/j.lanmic.2025.101307

Vancouver

Murtagh M, White PL, Rodriguez-Tudela JL, Alastruey-Izquierdo A, Chen SC, Dufresne PJ, et al. Global perspective on gaps in fungal diagnostics in low-resource settings: WHO landscape analysis and research priorities for invasive fungal diseases. The Lancet Microbe. 2026;7(5):101307. doi:10.1016/j.lanmic.2025.101307

BibTeX
@article{Murtagh2026,
  author = {Murtagh, Maurine and White, P Lewis and Rodriguez-Tudela, Juan Luis and Alastruey-Izquierdo, Ana and Chen, Sharon C-A and Dufresne, Philippe J and Gómez, Beatriz L and Garcia-Effron, Guillermo and Trainor, Betsy Wonderly and Garcia-Vello, Pilar and Bachmann, Till T and Ondoa, Pascale and Marcano Zamora, Daniel and Rocke, Tamarie and Cameron, Alexandra and Gigante, Valeria},
  title = {Global perspective on gaps in fungal diagnostics in low-resource settings: WHO landscape analysis and research priorities for invasive fungal diseases},
  journal = {The Lancet Microbe},
  year = {2026},
  volume = {7},
  number = {5},
  pages = {101307},
  doi = {10.1016/j.lanmic.2025.101307}
}
Kostenlos starten →